Datametrex Provides Update On Health Canada Submission & Welcomes Advisors Emerging Technology Investing
Hydroxychloroquine Side Effects Potentially Mitigated by Transdermal Delivery Pharmaceutical Investing
Codebase Ventures: Hydroxychloroquine Treatment for COVID-19 Benefits Sought in Global Research Effort to Establish Efficacy Blockchain Investing
Codebase Ventures Inc. Announces $1.5 Million Financing and First Closing of Financing Fintech Investing
Datametrex Obtains Rights to Import and Sell COVID-19 Test Kits From South Korea Emerging Technology Investing
PowerBand to Trademark DRIVRZ as Global Brand for Cloud-Based Consumer Platform to Buy, Sell, Lease and Trade Vehicles Emerging Technology Investing
Codebase to Invest in Company Developing Hydroxychloroquine Transdermal Treatment Blockchain Investing
PowerBand Secures USD $1.2 Million to Advance Cloud-based Platform Enabling Consumers and Dealers to Buy and Sell Automobiles From Anywhere Emerging Technology Investing
Datametrex Provides Additional Information On Its Co-bid To The Ministry Of Health In South Korea Surrounding COVID-19 Emerging Technology Investing
Datametrex Co-bid With LOTTE To The Ministry Of Health Surrounding Covid-19 Emerging Technology Investing
